Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe Holds Special Meeting for Shareholder Vote on Acquisition by Hologic

NEW YORK (GenomeWeb News) – Gen-Probe announced after the close of the market on Friday it will be holding a special shareholder meeting on July 31 during which shareholders will vote on the proposed $3.7 billion acquisition of the company by Hologic.

Hologic's bid for Gen-Probe, under which it would pay $82.75 per share of Gen-Probe's stock, was announced in April. Earlier this month, the deal cleared antitrust review by US regulators.

The special meeting will be held at Gen-Probe's headquarters in San Diego. Shareholders of Gen-Probe stock as of the end of the business day on June 29 are eligible to vote on the deal.

Planning efforts to integrate Gen-Probe into Hologic have already begun, and in June, a Hologic official said that once the deal is completed Gen-Probe would become the "hub" of Hologic's diagnostics business.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more